Back
Regulus Therapeutics Vs. Cassava Sciences Industry Stock Comparison
Sell
29
RGLS
Regulus Therapeutics
Last Price:
2.30
Seasonality Move:
-24.07%
Sell
47
SAVA
Cassava Sciences
Last Price:
22.04
Seasonality Move:
-5.06%
Sell
29
Regulus Therapeutics (RGLS)
is a Sell
Is Regulus Therapeutics a Buy, Sell or Hold?
- The current Regulus Therapeutics [RGLS] share price is $2.27. The Score for RGLS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- RGLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Cassava Sciences (SAVA)
is a Sell
Is Cassava Sciences a Buy, Sell or Hold?
- The current Cassava Sciences [SAVA] share price is $22.05. The Score for SAVA is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- SAVA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RGLS Stock Price Chart
What is Regulus Therapeutics's stock price today?
-
The Regulus Therapeutics share price today is $2.27
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGLS is experiencing selling pressure, which indicates risk of future bearish movement.
SAVA Stock Price Chart
What is Cassava Sciences's stock price today?
-
The Cassava Sciences share price today is $22.05
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SAVA is experiencing slight selling pressure.
RGLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 54.97 | Buy |
Chaikin Money Flow: | -1163464 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.99 - 2.43) | Buy |
Bollinger Bands (100): | (1.41 - 2.51) | Buy |
SAVA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.07 | Buy |
Relative Strength Index (14 RSI): | 51.15 | Buy |
Chaikin Money Flow: | -112102 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.25 - 22.63) | Buy |
Bollinger Bands (100): | (20.55 - 24.41) | Sell |
RGLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.06 | Buy |
20-day SMA: | 2.14 | Buy |
50-day SMA: | 2.4 | Sell |
200-day SMA: | 1.67 | Buy |
8-day EMA: | 2.13 | Buy |
20-day EMA: | 2.15 | Buy |
50-day EMA: | 2.18 | Buy |
200-day EMA: | 1.83 | Buy |
SAVA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.92 | Buy |
20-day SMA: | 21.87 | Buy |
50-day SMA: | 21.62 | Buy |
200-day SMA: | 21.49 | Buy |
8-day EMA: | 21.95 | Buy |
20-day EMA: | 21.9 | Buy |
50-day EMA: | 21.88 | Buy |
200-day EMA: | 22.49 | Sell |
Regulus Therapeutics Earnings Growth & RGLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.05 per share, an increase this year of $0.95 per share, and a decrease next year of $0.12 per share.
Cassava Sciences Earnings Growth & SAVA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and an increase next year of $1.37 per share.
Regulus Therapeutics Technical Analysis
May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cassava Sciences Technical Analysis
May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |